Literature DB >> 16461035

Relation of end-diastolic wall thickness and the residual rim of viable myocardium by magnetic resonance imaging to myocardial viability assessed by fluorine-18 deoxyglucose positron emission tomography.

Harald Peter Kühl1, Arno van der Weerdt, Aernout Beek, Frans Visser, Peter Hanrath, Albert van Rossum.   

Abstract

End-diastolic wall thickness (EDWT) and thickness of the residual non-contrast-enhanced myocardial rim have been suggested as markers for the assessment of myocardial viability by cardiovascular magnetic resonance (CMR) imaging. This study compared these parameters as derived from contrast-enhanced CMR images for the prediction of myocardial viability as determined by fluorine-18 deoxyglucose positron emission tomography (FDG-PET). Twenty-two patients with ischemic cardiomyopathy (ejection fraction 31 +/- 11%) were investigated. For contrast-enhanced CMR imaging, a standard inversion-recovery sequence was used. FDG-PET was performed using a hyperinsulinemic-euglycemic clamp. Data were analyzed with a 17-segment model. Of 146 severely dysfunctional segments, 112 were assessed as viable and 34 as nonviable by nuclear imaging. Using receiver-operator characteristic analysis, areas under the curve were 0.95 for unenhanced myocardial rim (95% confidence interval 0.92 to 0.98) and 0.86 for EDWT (95% confidence interval 0.80 to 0.93, p <0.001 vs unenhanced myocardial rim) for the prediction of viability as assessed by FDG-PET. Cutoffs of 5.4 mm for EDWT and 3.0 mm for unenhanced myocardial rim were found to optimally differentiate viability by FDG-PET. In 25 segments with divergent results, 94% of segments with an EDWT < or =5.4 mm and an unenhanced myocardial rim >3.0 mm were scored as viable by FDG-PET, whereas 57% of segments with an EDWT >5.4 mm and an unenhanced myocardial rim < or =3.0 mm were scored nonviable with the reference technique. In conclusion, unenhanced myocardial rim is superior to EDWT for the prediction of myocardial viability as determined by FDG-PET and may be clinically useful for assessment of myocardial viability in patients with ischemic cardiomyopathy and regional wall thinning.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16461035     DOI: 10.1016/j.amjcard.2005.09.074

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Characterization of myocardial viability using MR and CT imaging.

Authors:  Gabriele A Krombach; Thoralf Niendorf; Rolf W Günther; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

2.  Nuclear cardiology in the literature.

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

3.  Quantitation of the thickness of the non-enhanced myocardial rim predicts recovery of territorial myocardial function in chronic ischemic heart disease: a cardiac magnetic resonance imaging study.

Authors:  Tienush Rassaf; Johannes Nolte; Nicole Heussen; Gaby A Krombach; Rolf W Günther; Malte Kelm; Harald P Kühl
Journal:  Clin Res Cardiol       Date:  2010-02-12       Impact factor: 5.460

Review 4.  Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.

Authors:  Shahbudin H Rahimtoola; Vasken Dilsizian; Christopher M Kramer; Thomas H Marwick; Jean-Louis J Vanoverschelde
Journal:  JACC Cardiovasc Imaging       Date:  2008-07

5.  Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.

Authors:  Yen-Wen Wu; Eiji Tadamura; Shotaro Kanao; Masaki Yamamuro; Akira Marui; Masashi Komeda; Masanao Toma; Takeshi Kimura; Kaori Togashi
Journal:  Int J Cardiovasc Imaging       Date:  2007-03-16       Impact factor: 2.357

6.  Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation.

Authors:  Sigita Glaveckaite; Nomeda Valeviciene; Darius Palionis; Viktor Skorniakov; Jelena Celutkiene; Algirdas Tamosiunas; Giedrius Uzdavinys; Aleksandras Laucevicius
Journal:  J Cardiovasc Magn Reson       Date:  2011-07-25       Impact factor: 5.364

7.  The emerging role of magnetic resonance imaging and multidetector computed tomography in the diagnosis of dilated cardiomyopathy.

Authors:  Massimo Slavich; Anca Florian; Jan Bogaert
Journal:  Insights Imaging       Date:  2011-05-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.